These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 16293559)
1. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559 [TBL] [Abstract][Full Text] [Related]
2. [Clinical and histological features of non-alcoholic fatty liver disease]. Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638 [TBL] [Abstract][Full Text] [Related]
3. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462 [TBL] [Abstract][Full Text] [Related]
4. Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis. Tsang SW; Ng WF; Wu BP; Chow DA; Li ET; Wong TC J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):116-21. PubMed ID: 16706822 [TBL] [Abstract][Full Text] [Related]
5. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity]. Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634 [TBL] [Abstract][Full Text] [Related]
6. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982 [TBL] [Abstract][Full Text] [Related]
7. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [TBL] [Abstract][Full Text] [Related]
8. [Non-alcoholic fatty liver disease--new view]. Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346 [TBL] [Abstract][Full Text] [Related]
9. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD. Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862 [TBL] [Abstract][Full Text] [Related]
10. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473 [TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic steatohepatitis in children. Nanda K Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336 [TBL] [Abstract][Full Text] [Related]
12. Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension. Sorrentino P; Terracciano L; D'Angelo S; Ferbo U; Bracigliano A; Vecchione R Am J Gastroenterol; 2010 Feb; 105(2):336-44. PubMed ID: 19861959 [TBL] [Abstract][Full Text] [Related]